By physician referral or invitation only

COSMIC Trial for Children with Osteogensis Imperfecta

The purpose of this study is to investigate the effectiveness and safety of a medication for patients with Osteogenesis Imperfecta Types I, III, or IV.

Age & Gender

2 years ~ 6 years
Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Nina Jain
Pediatrics - Children's Research Institute

Study Type

Clinical or Medical
Interventional

Study Topics

Bones, Joints, Muscles
Genetics and Genetic Disorders

IRB Number

23-2980

ClinicalTrials.gov

TBD

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.